The high frequency of PTEN A333*fs10 represents a previously undervalued genomic variant in Chinese NSCLC, and the future functional characterization of this variant for clinical diagnosis and drug development is well justified. The gene discussed is PTEN; the disease is non-small cell lung carcinoma.